Showing results (261-270 of 271) with videos related to

Sort By:
Pageof 28
Journal of the International Neuropsychological Society : JINS|March 21, 2019
Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning CorrelatesRowan Saloner, Laura M Campbell, Vanessa Serrano, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2023
Antiretroviral Therapy Intensification for Neurocognitive Impairment in Human Immunodeficiency VirusScott L Letendre, Huichao Chen, Ashley McKhann, et al.
Journal of Neurovirology|February 15, 2013
Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disordersE E Morgan, S P Woods, S L Letendre, et al.
Virology|September 25, 2012
Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairmentGeorge K Hightower, Joseph K Wong, Scott L Letendre, et al.
Neurology|May 13, 2014
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic declineIgor Grant, Donald R Franklin, Reena Deutsch, et al.
Journal of Neurovirology|May 6, 2011
Clinical factors related to brain structure in HIV: the CHARTER studyTerry L Jernigan, Sarah L Archibald, Christine Fennema-Notestine, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 28, 2017
Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group studyPeilin Jia, Zhongming Zhao, Todd Hulgan, et al.
Journal of Neurovirology|July 11, 2013
Increases in brain white matter abnormalities and subcortical gray matter are linked to CD4 recovery in HIV infectionChristine Fennema-Notestine, Ronald J Ellis, Sarah L Archibald, et al.
Neurology|December 8, 2010
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER StudyR K Heaton, D B Clifford, D R Franklin, et al.
Pageof 28